Intra-Cellular Therapies Inc. Stock Forecast
Intra-Cellular Therapies Inc. stock upgraded to Buy Candidate.
(Updated on Jun 17, 2024)
The Intra-Cellular Therapies Inc. stock price gained 1.62% on the last trading day (Monday, 17th Jun 2024), rising from $67.77 to $68.87. During the last trading day the stock fluctuated 3.18% from a day low at $67.91 to a day high of $70.07. The price has been going up and down for this period, and there has been a 0.67% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 94 thousand more shares were traded than the day before. In total, 705 thousand shares were bought and sold for approximately $48.57 million.
The stock is moving within a wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Intra-Cellular Therapies Inc. stock with a 90% probability to be traded between $63.22 and $77.43 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
ITCI Signals & Forecast
Mostly positive signals in the chart today. The Intra-Cellular Therapies Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $68.55 and $67.86. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, May 10, 2024, and so far it has risen 6.02%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. The stock had a Golden Star Signal on Friday, April 05, 2024 in the short-term chart.
Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.
Golden Star
The stock had a Golden Star Signal on Friday, April 05, 2024 in the short-term chart.Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.
Support, Risk & Stop-loss for Intra-Cellular Therapies Inc. stock
Intra-Cellular Therapies Inc. finds support from accumulated volume at $68.41 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $2.16 (3.18%) between high and low. For the last week, the stock has had daily average volatility of 3.54%.
Our recommended stop-loss: $66.35 (-3.66%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 43 days ago.)
Trading Expectations (ITCI) For The Upcoming Trading Day Of Tuesday 18th
For the upcoming trading day on Tuesday, 18th we expect Intra-Cellular Therapies Inc. to open at $68.95, and during the day (based on 14 day Average True Range), to move between $66.57 and $71.17, which gives a possible trading interval of +/-$2.30 (+/-3.34%) up or down from last closing price. If Intra-Cellular Therapies Inc. takes out the full calculated possible swing range there will be an estimated 6.68% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $68.41 (0.67%) than the resistance at $72.00 (4.54%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Intra-Cellular Therapies Inc. stock A Buy?
Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Intra-Cellular Therapies Inc. stock to perform well in the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.
Current score: 2.659 Buy Candidate Upgraded
Predicted Opening Price for Intra-Cellular Therapies Inc. of Tuesday, June 18, 2024
Fair opening price June 18, 2024 | Current price |
---|---|
$68.95 ( 0.116%) | $68.87 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for ITCI
Fibonacci Support & Resistance Levels
Level | Price | |
---|---|---|
R3 | 71.11 | 3.25% |
R2 | 70.28 | 2.05% |
R1 | 69.78 | 1.31% |
Price | 68.87 | |
S1 | 68.12 | -1.08% |
S2 | 67.62 | -1.82% |
S3 | 66.79 | -3.02% |
Accumulated Volume Support & Resistance Levels
Level | Price | |
---|---|---|
R3 | 79.84 | 15.93% |
R2 | 76.69 | 11.35% |
R1 | 72.00 | 4.54% |
Price | 68.87 | |
S1 | 68.41 | -0.668% |
S2 | 67.21 | -2.41% |
S3 | 67.00 | -2.72% |
FAQ
Click here for our free guide on how to buy Intra-Cellular Therapies Inc. Stock.